Your browser is no longer supported. Please, upgrade your browser.
Eton Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.40 Insider Own8.10% Shs Outstand21.01M Perf Week-8.87%
Market Cap194.11M Forward P/E26.37 EPS next Y0.30 Insider Trans-43.30% Shs Float17.43M Perf Month9.41%
Income-28.00M PEG- EPS next Q0.19 Inst Own35.80% Short Float6.95% Perf Quarter-19.94%
Sales0.04M P/S4977.22 EPS this Y-29.10% Inst Trans-0.05% Short Ratio6.32 Perf Half Y11.57%
Book/sh0.75 P/B10.55 EPS next Y22.45% ROA-160.90% Target Price13.50 Perf Year44.87%
Cash/sh0.87 P/C9.11 EPS next 5Y- ROE-322.40% 52W Range4.32 - 10.30 Perf YTD-2.71%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-23.20% Beta-
Dividend %- Quick Ratio6.20 Sales past 5Y- Gross Margin- 52W Low82.89% ATR0.45
Employees16 Current Ratio6.50 Sales Q/Q-80.00% Oper. Margin- RSI (14)46.57 Volatility6.02% 5.95%
OptionableYes Debt/Eq0.45 EPS Q/Q-143.30% Profit Margin- Rel Volume0.89 Prev Close8.09
ShortableYes LT Debt/Eq0.43 EarningsMar 16 AMC Payout- Avg Volume191.81K Price7.91
Recom2.00 SMA20-2.35% SMA500.96% SMA2000.45% Volume170,105 Change-2.22%
Jan-04-21Reiterated H.C. Wainwright Buy $20 → $15
Sep-20-19Initiated B. Riley FBR Buy $13.50
Jun-10-19Initiated H.C. Wainwright Buy $15
May-06-21 03:00PM  
May-04-21 04:05PM  
Apr-16-21 07:49AM  
Mar-17-21 04:05PM  
Mar-16-21 05:15PM  
Mar-09-21 12:30PM  
Mar-04-21 04:05PM  
Feb-16-21 04:05PM  
Feb-15-21 12:13AM  
Feb-08-21 09:28AM  
Jan-15-21 09:05AM  
Jan-14-21 08:00AM  
Dec-17-20 08:00AM  
Nov-29-20 05:13PM  
Nov-24-20 09:00AM  
Nov-17-20 01:53AM  
Nov-12-20 04:05PM  
Nov-04-20 04:05PM  
Nov-02-20 07:04AM  
Oct-21-20 11:58AM  
Oct-16-20 04:05PM  
Oct-15-20 08:30AM  
Oct-14-20 08:30AM  
Oct-13-20 04:01PM  
Oct-08-20 08:00AM  
Oct-06-20 04:05PM  
Sep-30-20 06:57PM  
Sep-29-20 06:50PM  
Sep-25-20 11:24AM  
Sep-17-20 10:11AM  
Sep-16-20 09:00AM  
Sep-01-20 06:05PM  
Aug-31-20 08:00AM  
Aug-12-20 09:45AM  
Aug-11-20 09:00AM  
Aug-04-20 04:10PM  
Jul-30-20 08:00AM  
Jul-27-20 07:30AM  
Jun-04-20 06:16PM  
May-14-20 05:25PM  
May-07-20 12:30PM  
May-06-20 04:30PM  
May-04-20 08:00AM  
Apr-28-20 12:33PM  
Apr-16-20 12:13PM  
Mar-30-20 09:56AM  
Mar-27-20 07:00AM  
Mar-26-20 12:00PM  
Mar-17-20 08:00AM  
Mar-06-20 08:49AM  
Mar-05-20 06:25PM  
Feb-27-20 04:10PM  
Feb-21-20 07:08AM  
Feb-19-20 08:00AM  
Feb-13-20 04:05PM  
Jan-21-20 07:00AM  
Dec-31-19 12:46PM  
Dec-22-19 01:23PM  
Dec-02-19 07:30AM  
Nov-14-19 04:01PM  
Nov-13-19 04:55PM  
Nov-12-19 08:27AM  
Nov-06-19 04:05PM  
Oct-22-19 07:00AM  
Sep-19-19 11:53AM  
Sep-13-19 09:00AM  
Sep-03-19 04:01PM  
Aug-19-19 05:55PM  
Aug-14-19 09:10AM  
Aug-13-19 09:50AM  
Aug-12-19 08:37AM  
Aug-07-19 11:20AM  
Aug-06-19 07:01AM  
Aug-02-19 09:06AM  
Aug-01-19 08:01AM  
Jul-30-19 08:01AM  
Jul-25-19 07:30AM  
Jul-16-19 08:17AM  
Jul-15-19 02:07PM  
Jul-12-19 04:24PM  
Jun-25-19 03:17PM  
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. It also develops ET-105, a lamotrigine for oral suspension; DS-300, a cysteine injection; DS-100, a dehydrated alcohol injection; ET-104, a zonisamide oral suspension; ET-101, a topiramate oral suspension; and ET-203, an ephedrine ready-to-use injection. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HARROW HEALTH, INC.10% OwnerApr 12Sale7.001,518,00010,626,0001,982,000Apr 12 07:55 PM
Opaleye Management Inc.10% OwnerOct 16Buy7.00400,0002,800,0003,885,000Oct 16 09:30 PM